Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 11:43 am Sale | 2025-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 9,749,724 4.700% | -205,251 (-2.06%) | Filing History |
| 2025-11-12 3:32 pm Sale | 2025-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | WASATCH ADVISORS LP | 7,061,857 3.500% | -3,869,400 (-35.40%) | Filing History |
| 2025-08-13 5:47 pm Purchase | 2025-06-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 9,954,975 5.000% | 3,370,697 (+51.19%) | Filing History |
| 2025-04-07 2:15 pm Sale | 2025-03-31 | 13G | Esperion Therapeutics, Inc. ESPR | WASATCH ADVISORS LP | 10,931,257 5.500% | -4,232,629 (-27.91%) | Filing History |
| 2025-03-10 11:12 am Sale | 2025-03-04 | 13G | Esperion Therapeutics, Inc. ESPR | BB BIOTECH AG | 9,694,064 4.900% | -250,000 (-2.51%) | Filing History |
| 2025-02-14 2:37 pm Purchase | 2024-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB BIOTECH AG | 9,944,064 5.000% | 750,000 (+8.16%) | Filing History |
| 2024-11-14 08:42 am Sale | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 6,584,278 3.300% | -1,101,842 (-14.34%) | Filing History |
| 2024-11-12 2:23 pm Unchanged | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | VANGUARD GROUP INC | 13,043,077 6.640% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | BlackRock Inc. BLK | 14,265,367 7.300% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:33 pm Unchanged | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | VANGUARD GROUP INC | 13,043,077 6.640% | 0 (Unchanged) | Filing History |
| 2024-11-04 12:09 pm Purchase | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | VANGUARD GROUP INC | 13,043,077 6.640% | 7,905,327 (+153.87%) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | BlackRock Inc. BLK | 14,265,367 7.300% | 9,620,008 (+207.09%) | Filing History |
| 2024-10-17 4:34 pm Sale | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 3,403,530 1.700% | -6,772,999 (-66.56%) | Filing History |
| 2024-06-12 4:26 pm Purchase | 2024-06-10 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 10,176,529 5.400% | 6,532,578 (+179.27%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 0 0.000% | -5,500,000 (Position Closed) | Filing History |
| 2024-02-14 10:50 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 7,686,120 6.800% | -236,050 (-2.98%) | Filing History |
| 2024-02-14 08:42 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Deep Track Capital, LP | 0 0.000% | -6,345,790 (Position Closed) | Filing History |
| 2024-02-14 06:11 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 209,971 0.200% | -4,323,785 (-95.37%) | Filing History |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Esperion Therapeutics, Inc. ESPR | VANGUARD GROUP INC | 5,137,750 4.520% | 877,286 (+20.59%) | Filing History |
| 2024-02-09 4:14 pm Purchase | 2024-02-09 | 13G | Esperion Therapeutics, Inc. ESPR | WASATCH ADVISORS LP | 15,163,886 12.600% | 5,362,725 (+54.72%) | Filing History |